The new analysis of a Pear Therapeutics-based randomized controlled trial came along another investigation that spotted early signs of treatment dropout.
from News from healthcareitnews.com https://ift.tt/2YREUsP
via IFTTT
Monday, August 31, 2020
Home »
News from healthcareitnews.com
» Pear's Somryst precursor improved sleep health measures among patients with chronic insomnia and depressive symptoms
0 comments:
Post a Comment